目前有证据显示急诊冠脉介入治疗(PCI)对于多数ST段抬高的心肌梗死(STEMI)是一种效果较好的再灌注策略,但仅有少部分的患者接受了急诊PCI治疗,在这些人群中,又仅有一小部分在入院90min之内接受了治疗。美国心脏协会(AHA)进行的市场调研发现,在STEMI患者的施治过程中存在着很多 There is currently evidence that emergency PCI is a more effective reperfusion strategy for most patients with ST-elevation myocardial infarction (STEMI), but only a minority of patients underwent emergency PCI. Of these In the population, only a small percentage of patients receive treatment within 90 minutes of admission. A market research conducted by the American Heart Association (AHA) found that there was a significant amount of treatment in STEMI patients